@article{article, title = {{Vedolizumab for Treating Moderately to Severely Active Crohn鈥檚 Disease After Prior Therapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal}},
url = {{http://eprints.whiterose.ac.uk/106724/ }},
year = {{2016}},
month = {{8}},
author = {{Rafia R and Scope A and Harnan S and Stevens JW and Stevenson M and Lobo A}},
doi = {{10.1007/s40273-016-0436-6}},
volume = {{34}},
journal = {{PharmacoEconomics}},
issue = {{12}},
pages = {{1241-1253}},
note = {{Accessed on 2025/07/08}}}